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?????????????????????????????????????????????????????? ?????????????????????
Periodontal disease has been associated with elevations of blood cytokines involved in atherosclerosis in systemically healthy individuals, but little is known about this 
association in stable cardiovascular patients. The aim of this study was to assess the 
association between periodontal disease (exposure) and blood cytokine levels (outcomes) 
in a target population of patients with stable coronary artery disease (CAD). Material and 
Methods: This cross-sectional study included 91 patients with stable CAD who had been 
?????????? ???????????????????????????????????????????????????????????????????????????????
TNF-? were measured by Luminex technology. A full-mouth periodontal examination was 
conducted to record probing depth (PD) and clinical attachment (CA) loss. Multiple linear 
regression models, adjusting for gender, body mass index, oral hypoglycemic drugs, 
smoking, and occurrence of acute myocardial infarction were applied. Results: CAD patients 
?????????????????????????????????????????????????????????????????????????????????????
vs. 3.01 pg/mL; p=0.01), IL-10 (median: 2.33 pg/mL vs. 1.01 pg/mL; p=0.03), and TNF-? 
(median: 9.17 pg/mL vs. 7.47 pg/mL; p=0.02). Higher numbers of teeth with at least 6 
????????????????????????????????????????? ???????????????????????????? ?????????????????
???????????????????? ??????????????????????????????????????? ????????????????????????????
IL-10 concentrations. Elevated concentrations of TNF-? were associated with higher mean 
CA loss (R2=0.07). Conclusion: Periodontal disease is associated with increased systemic 
?????????????????????????????????????????????????????????????????????????????????????????
supporting the idea that periodontal disease can be a prognostic factor in cardiovascular 
patients.
Keywords: Cytokines. Cardiovascular diseases. Periodontal diseases. Atherosclerosis. 
Interleukins.
INTRODUCTION
???????????? ?????? ??? ? ???????? ????? ??? ????
initiation and development of atherosclerosis19. 
Atherosclerotic lesions are comprised of various 
??????????????????????????????????????????????????
cytokines, which participate in the plaque formation 
cascade in vessel walls12?? ????????????? ????????????
(IL)-6, tumor necrosis factor (TNF)-a, and interferon 
???????? ???? ?????? ??? ????????? ??????????????? ???
blood from cardiovascular patients22,29, and the IL-
10 concentration is increased in unstable compared 
with stable atheromas18. Moreover, IL-6 and TNF-a 
have direct effects on the production and release of 
C-reactive protein (CRP)20 and, consequently, have 
been used as predictors of future cardiovascular 
events in cardiac patients11.
Periodontal diseases are caused by bacteria 
attached to teeth in organized biofilms and is 
characterized by bleeding, loss of tooth surrounding 
tissues, and tooth mobility, being the major cause 
of halitosis and tooth loss. Periodontal diseases may 
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be expressed using various clinical parameters and 
??????????????????????????????????????????????????
factors and systemic conditions26. Probing depth 
and clinical attachment loss are the most frequent 
?????????????????????????????????????????????????
health/disease status, and they may be expressed 
as individual averages or by the number of teeth 
affected per individual.
One of the possible mechanism linking periodontal 
diseases to cardiovascular diseases (CVD) is the 
?????????? ???????????? ??????? ?????????? ????? ????
periodontal etiopathogenic process14,22. Studies 
have demonstrated that periodontitis, which is the 
destructive form of periodontal disease, increases 
systemic levels of some of the aforementioned 
CVD-related cytokines3,15. Most evidence supporting 
this claim has been provided by studies conducted 
in otherwise systemically healthy individuals, 
suggesting that periodontal disease may be a 
risk factor for CVD. On the other hand, there 
is little information about the systemic effects 
of periodontal disease on patients with stable 
CVD, with few studies evaluating the association 
between periodontal disease and a small number of 
??????????????????????????????????????????????????
patients2,8,10,17,28.
To the best of the authors’ knowledge, no study 
has evaluated the association between periodontal 
parameters and blood levels of a broad range of 
cytokines, assessed by Multiplex technology, in 
cardiovascular patients. Such studies may indicate 
?? ??????????? ??????? ??? ???????????? ????????????
and destruction in the occurrence of future 
cardiovascular events on these patients. Therefore, 
the aim of this study was to assess the associations 
between periodontal disease and blood cytokine 
levels in patients with stable CAD who were under 
standard cardiovascular care.
MATERIAL AND METHODS
This cross-sectional observational study was 
conducted with stable CAD patients who had been 
receiving cardiovascular care for at least six months 
in a tertiary care cardiovascular clinic at a university 
hospital in Brazil. To be included in the study, all 
????????????????????????????????????????????????
occurrence of at least one of the following events 
six months before entering the study: documented 
history of myocardial infarction (MI), stable 
angina, or ischemia in noninvasive tests; surgical 
or percutaneous myocardial revascularization and 
lesion size greater than 50% in at least one major 
coronary artery, as assessed by angiography; 
and presence of angina and positive results of 
noninvasive testing of ischemia. Additional inclusion 
criteria included the presence of at least four teeth, 
no periodontal treatment, and no use of antibiotics 
??????????????????????????????????????????????????
the study.
Overall, 239 consecutive patients were evaluated 
from April to December 2011. Among them, 78 
(32.6%) individuals had less than four teeth, 30 
(12.6%) refused participation, and 17 (7.1%) 
lived outside the city and were not available for 
clinical examination. Moreover, 16 (6.7%) did 
not attend the clinical examination appointment. 
Clinical examinations were performed in 98 (41.0%) 
individuals; however, seven did not undergo 
??????????????????????????????????????????????????
present investigation comprised 91 individuals.
The study protocol was approved by the 
institutional review boards of the University Hospital 
and the Federal University of Rio Grande do Sul. All 
participants read and signed an informed consent 
form before entering the study.
Cardiovascular care
All patients received cardiovascular tertiary care 
including medication and counseling. Regarding 
drug prescription, the protocol of the cardiovascular 
care in this clinic includes statins for the majority of 
patients. When appropriate, oral hypoglycemic drugs, 
insulin, acetylsalicylic acid, and antihypertensives 
were also prescribed. Counseling mainly includes 
daily exercise, smoking cessation, and dietary 
therapy. Most patients in this sample were using 
statins (92.3%), acetylsalicylic acid (90.1%), 
and antihypertensive drugs (93.4%). Only 13.1% 
and 9.9% were using insulin and antidepressives, 
respectively.
Data collection
We applied a structured questionnaire to collect 
data about age, gender, and smoking exposure. We 
obtained medical history, medication use, weight, 
and height from the hospital records of the patients.
Clinical periodontal parameters were assessed 
with a manual periodontal probe (Williams probe, 
Newmar, São Paulo, SP, Brazil) by two calibrated 
examiners (weighted kappa values ranging from 0.80 
and 0.90) who were unaware of the cardiovascular 
????????? ???????????? ?????????? ??? ???? ??????????
Visible plaque (VP), gingival recession (GR), probing 
depth (PD), and bleeding on probing (BOP) were 
recorded at six sites per tooth in all present teeth, 
excluding third molars. Clinical attachment (CA) loss 
was obtained as the sum of GR and PD.
Blood samples
A trained nurse collected 20 mL of blood from the 
antecubital fossa of each individual. Fasting blood 
samples were obtained between 7:00 am and 12:00 
pm to control for possible diurnal variations. Half of 
the blood (10 mL) was stored in EDTA-containing 
Eppendorf tubes and was immediately centrifuged 
???????????????????????????????????????????????????????????????????????????????????????????????????
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for analysis. Plasma from the remaining 10 mL 
????????????????????????????????????????????????????
Samples were stored for two years on average.
Cardiovascular status
The cardiovascular status of patients was 
assessed by identifying known blood markers of 
risk for cardiovascular events. High-sensitivity CRP, 
glucose, glycated hemoglobin, triglycerides (TG), 
total cholesterol (TC), and high-density lipoprotein 
cholesterol (HDL-C) were measured as previously 
described8. Low-density lipoprotein cholesterol 
(LDL-C) was calculated by the Friedwald formula.
Participants were further divided into those 
having medium- and long-term past history of 
major cardiovascular events using a combination of 
information about the occurrence of cardiovascular 
events and time elapsed since the event. Patients 
that have experienced acute myocardial infarction 
or myocardial revascularization (angioplasty or 
surgery) in the last nine years were included in the 
high status group, whereas if the events occurred 
before 10 years or more, the individuals were 
??????????????????????????????????
Systemic cytokines
??????????????????????????????????????????????????
??????????????? ?????????????????????????????????
methodology in combination with the 3.1 Xponent 
software package (Luminex Corp., Austin, TX, USA 
). The MILLIPLEX MAP Human Cytokine/Chemokine 
Magnetic Bead Panel-07 kit (HCYTOMAG-60k, EMD 
Millipore, Saint Charles, USA) was used following the 
manufacturer’s instructions. Results were expressed 
as standard curve units in pg/mL. All samples were 
analyzed at the same time under standardized 
experimental conditions.
In summary, before starting the immunoassay, 
samples were completely thawed, mixed by 
vortexing, and centrifuged at 1000g for 10 minutes 
to remove particulates. All kit reagents were 
????????????????????????????????????????????????
of wash buffer was added to each of the 96 wells 
in the plate, which was then sealed, mixed on a 
plate shaker for 10 minutes at room temperature, 
inverted, and tapped several times onto absorbent 
towels to decant and remove the residual wash 
buffer. The standard curve and control wells received 
??? ??? ??? ????????? ??????? ???????? ??????????? ????
???????????????? ????????? ??? ??? ??? ???? ?????????
Assay buffer alone was used as the background (0 
??????????????????????????????????????????????????
????????????????????????per well.
Each antibody-bead vial was sonicated for 30 
??????????????????????????? ????????????????????????
each antibody-bead vial were added to the mixing 
??????????????????????????????????????????????????
?????????????????????????????????????????? ??????????
to each well. The plate was sealed and incubated 
overnight (18 hours) at 4°C with agitation on a plate 
shaker. Well contents were gently removed, and the 
?????????????????????????????????????????????????
aliquot of detection antibodies was added to each 
well and incubated for 1 hour at room temperature 
with agitation on a plate shaker. Without further 
??????????????????????????????????????????????????
added to each well, followed by incubation for 
another 30 minutes with agitation on a plate shaker. 
Washing with wash buffer was repeated twice. 
??????????????????????????????? ????????????????? ??????
The beads were re-suspended on a plate shaker for 
5 minutes, and the plate was run on Luminex. The 
???????????????????????????? ?????????????????????
???????????????? ????????? ???????????????????? ????
calculating cytokine concentrations in the samples.
Statistical analysis
The outcomes of the present study were 
?????? ??????? ??? ???????????? ??????????? ???????
????? ??????????? ?????? ???? ????? ??? ???? ??????????
?????????????????????????????????????????????????????. 
Cardiovascular blood markers (CRP, TG, lipids, 
glucose, glycated hemoglobin) were expressed as 
means and standard deviations (SD) to describe the 
????????????????????????????????????
Numbers of teeth with PD and CA loss of 6 mm or 
????????????????????????????????????????????????????
as having severe periodontitis in the presence of two 
or more interproximal sites with CA loss of 6 mm or 
greater and at least one interproximal site with PD 
of 5 mm or greater in nonadjacent teeth7.
Multiple linear regression models were used to 
study the association between periodontal status 
and systemic levels of cytokines. In these models, 
???????????? ??????? ???? ??????? ??? ????? ??????????
mean CA loss, mean PD, and numbers of teeth 
with CA loss of at least 6 mm and PD of at least 6 
mm. Cytokine concentrations were log-transformed 
?????????????????????? ?????? ???????????????????????
periodontal status as the main independent variable 
and adjusting them for gender, body mass index 
(BMI), use of oral hypoglycemic drugs, lifetime 
smoking exposure (in packyears), and time elapsed 
since the occurrence of acute myocardial infarction. 
??????????????? ????? ??? ??????? ???? ??????? ??? ????
???????? ??????????? ????????????? ????????? ???????
(SE), and adjusted R2 values were determined. It 
has been suggested that the levels of triglycerides 
may modify the production of cytokines5. Thus, an 
???????????? ????????????? ?????????? ??? ??????????
comparisons according to the TG control status, 
with 150 mg/dL as the cut-off.
Secondary analysis was performed using 
diagnostic tests to estimate the magnitude 
severe periodontitis that may predict higher 
levels of systemic cytokines. Cytokine levels were 
??????????????????????????????????? ???????????????????????????????????????????????
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dichotomized by the median value. Sensitivity, 
???????????? ???? ????????? ???? ????????? ???????????
values (PPV and NPV, respectively) were calculated 
for severe periodontitis and each cytokine.
Statistical analyses were performed with a 
statistical package (STATA SE for Macintosh version 
13, StataCorp, College Station, USA). The individual 
was the unit of analysis. The alpha level was set 
at 5%.
RESULTS
The mean age of the sample was 62.9 (SD: 9.9) 
years and the average lifetime smoking exposure 
equaled 21.8 (SD: 31.9) packyears. Table 1 describes 
the characteristics of the sample. Considering the 
observed mean values, cardiovascular patients 
from the present study had elevated levels of CRP 
and TG, whereas TC, HDL, and LDL were mostly 
?????? ????????? ???? ??????? ??? ?????????? ??????????
observed. Overall, 68 (76.4%) individuals had 
severe periodontitis.
A total of 52 (57.1%) patients experienced 
acute myocardial infarction, and more than half of 
these patients had this major event during the nine 
years before the study (medium-term past history 
of events). CAD patients in the medium-term past 
history, compared with the long-term group, had 
????????????????????????????????????????????????????
and TNF-? (Table 2).
?????? ????? ??????????? ????????????? ????????
???????????? ??????????? ???? ??????? ??????? ????
?????? ??????? ????????? ???????? ??? ??????????????
loss (R2=0.07) and PD of at least 6 mm (R2=0.06) 
????? ????????????? ??????????? ????? ??????? ??????
concentrations. Mean CA loss (R2=0.05) and PD 
(R2???????????? ????????????? ???????? ??? ???? ??????
??????????????????????????????????????????????????
associated with higher mean CA loss (R2=0.07). 
?????? ????? ??? ??????????? ????????????? ????????
?????????????????????????????????????????????????
Table 4 shows multiple linear regression models 
of the association between clinical attachment 
loss and serum cytokines (log transformed) 
according to triglyceride control. In individuals 
????? ??????? ??????????? ??? ?????????????? ????
number of teeth with CA loss of at least 6 mm was 
Characteristic n (%)
??????????????? ? 54 (59.3)
???????????????????? ?
Non-smoker 35 (38.4)
Former smoker 46 (50.6)
Smoker 10 (11.0)
BMI (Kg/m2) 27.84±4.56
Periodontal status Mean ± SD
?????????????????? 67.9±20.3
PD (mm) 3.0±0.7
CA loss (mm) 4.8±1.6
??????? 74.7±24.2
Tooth loss (number of teeth) 12.9±7.0
Cardiovascular variables Mean ± SD
CRP (mg/L) 4.50±5.25
Triglycerides (mg/dL) 179±132
Total cholesterol (mg/dL) 167±30
LDL-C (mg/dL) 89±28
HDL-C (mg/dL) 42±12
Glucose (mg/dL) 122±46
??????????????????????? 6.98±2.07
Cytokines Mean ± SD
????????????? 5.23±9.55
IL-10 (pg/mL) 4.79±12.97
????????????? 1.26±2.79
IL-6 (pg/mL) 2.81±2.61
IL-8 (pg/mL) 6.65±5.64
TNF-? (pg/mL) 10.09±5.80
Table 1- Demographic and behavioral characteristics of 
the study sample (n=91)
Past history of cardiovascular events
Cytokines Long-term Medium-term
????????????? 3.01 (0.76-34.13) 5.06 (0.90-84.89)
IL-10 (pg/mL) 1.01 (0.05-20.06) 2.33 (0.05-88.47)
????????????? 0.66 (0.05-4.7) 0.71 (0.05-26.46)
IL-6 (pg/mL) 1.92 (0.59-15.60) 2.13 (0.38-11.70)
IL-8 (pg/mL) 4.45 (1.45-30.00) 4.97 (1.53-27.82)
TNF-? (pg/mL) 7.47 (4.00-34.02) 9.17 (2.81-63.18)
?????????????????????????????????????????????????????????????????????????????????????????????
Table 2- Concentrations of blood cytokines according to cardiovascular status of the sample (values expressed as median, 
minimum – maximum)
???????????????????????????????????????????????????????????????????????????????????????????????????
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??????????????????????????????????????????????????
???????????????????????????????????????????????????
found for IL-6, IL-8, and TNF-?. 
Diagnostic tests of severe periodontitis as a 
predictor of cytokine concentrations above the 
median are shown in Table 5. A positive diagnosis 
of periodontitis indicated sensitivity values ranging 
between 77.8 and 84.4, whereas the absence of 
??????????????????????????????????????????????????????
(range: 20.0–31.8). PPVs were close to 50.0, and 
???????????????????????????????????????????????????
DISCUSSION
The present study demonstrated that periodontal 
???????? ??? ???????????????? ????????? ????????????
??? ????????? ????? ???????? ????? ????????????? ?????
periodontal condition, as measured by CA loss and 
PD, was associated with increased blood levels of 
???????????????????????. These cytokines were also 
related to major events in the studied sample. These 
???????????????????????????????????????????????????
notion that periodontal disease may be a prognostic 
factor in cardiovascular patients.
Mean CA loss Mean PD ?????????????????????? ? ????????????????? ?
Cytokine beta±SE R2 beta±SE R2 beta±SE R2 beta±SE R2
????? 0.02±0.02 0.03 0.05±0.04 0.04 0.02±0.01 0.07 0.02±0.01 0.06
IL-10 0.07±0.03 0.05 0.12±0.06 0.06 0.02±0.01 0.04 0.03±0.02 0.05
????? 0.001±0.03 0.03 0.002±0.06 0.03 -0.01±0.01 0.04 -0.01±0.02 0.03
IL-6 0.02±0.02 0.02 0.03±0.04 0.02 0.003±0.01 0.01 0.01±0.01 0.02
IL-8 0.01±0.02 0.05 -0.03±0.03 0.06 0.01±0.01 0.05 -0.01±0.01 0.06
TNF-? 0.02±0.01 0.07 0.02±0.02 0.04 -0.001±0.01 0.03 -0.002±0.01 0.03
???????????????????????????????????????????????????????? ?
Table 3- Multiple linear regression models of the association between periodontal status and serum cytokines (log 
transformed), with adjustment for gender, body mass index, use of oral hypoglycemic drugs, smoking exposure, and time 
elapsed since major cardiovascular event
???????????????????????????????? ?
??????????????????? ???? Triglycerides <150 mg/dL
Cytokine beta±SE R2 beta± SE R2
????? 0.04±0.02 0.19 0.01±0.01 0.08
IL-10 0.03±0.01 0.1 0.01±0.02 0.02
????? 0.06±0.03 0.1 0.01±0.01 0.17
IL-6 0.001±0.01 0.04 0.003±0.01 0.03
IL-8 0.001±0.01 0.18 0.01±0.01 0.06
TNF-? 0.01±0.01 0.24 0.001±0.01 0.04
Table 4- Multiple linear regression models of the association between clinical attachment loss and serum cytokines (log 
transformed) according to triglyceride control
Sensitivity ?????????? Positive predictive 
value
Negative predictive 
value
????? 84.4 (70.5-93.5) 31.8 (18.6-47.6) 55.9 (43.3-67.9) 66.7 (43.0-85.4)
IL-10 77.8 (62.9-88.8) 25.0 (13.2-40.3) 51.5 (39.0-63.8) 52.4 (29.8-74.3)
????? 73.5 (58.9-85.1) 20.0 (9.1-35.6) 52.9 (40.4-65.2) 38.1 (18.1-61.6)
IL-6 77.8 (62.9-88.8) 25.0 (13.2-40.3) 51.5 (39.0-63.8) 52.4 (29.8-74.3)
IL-8 82.6 (68.6-92.2) 30.2 (17.2-46.1) 55.9 (43.3-67.9) 61.9 (38.4-81.9)
TNF-? 77.8 (62.9-88.8) 25.0 (13.2-40.3) 51.5 (39.0-63.8) 52.4 (29.8-74.3)
Table 5-? ??????????? ?????? ??? ??????? ?????????????? ??? ?? ?????????? ??? ????????? ??????????????? ?????? ???? ??????? ?????
??????????????????????????????????
??????????????????????????????????? ???????????????????????????????????????????????
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The role of IL-10 in the cascade of atherosclerosis 
and cardiovascular events remains controversial, 
with some studies indicating that high IL-10 
concentrations may have a protective effect on 
MI9,23 and other longitudinal observational studies4,16 
reporting that baseline elevated blood IL-10 levels 
increase the risk for MI. This controversy seems 
to have been clarified by a recently published 
meta-analysis13, which demonstrated that high IL-
??? ?????? ??????? ???? ????????????? ????????????????
new cardiovascular events over time in patients 
with acute coronary syndrome. If IL-10 is truly 
related to new major cardiovascular events, then 
periodontal disease might have a detrimental effect 
on atherosclerosis by increasing the levels of IL-10, 
as demonstrated in this study. Nevertheless, the 
possible effect of other confounders not assessed in 
the present study and which may be related to the 
association found between periodontal status and 
IL-10 should not be discarded.
??????????????? are proatherogenic cytokines21. 
?????? ????? ??? ?????????????? ?????? ??? ???????????
collagen production and smooth cell proliferation, 
thereby altering the plaque composition and 
stability30???????? ??? ????????? ??? ??????? ???????????
IL-6 production27. In the present study, clinical 
parameters of periodontal inflammation and 
???????????? ???????????????????????????? ??????????
??????????????????????????????????????????????????
disease may act in early stages of the cascade of 
atherogenic events in cardiovascular patients by 
????????????????????????????????????????.
The IL-6 cytokine is directly involved in the 
hepatic production of CRP20. Periodontal disease 
was not associated with blood levels of IL-6 in the 
present sample of cardiovascular patients. However, 
very low levels of this cytokine were detected in our 
patients, probably due to the cardiovascular care 
received by using statins. Such low levels may have 
hindered possible associations between periodontal 
status and this cytokine.
????????????????????? ????????????? ??????????????
association between periodontal tissue breakdown 
and some cytokines in this study. The systemic 
??????????????????????????????????????????????????
??? ??????? ??????? ???? ?????????? ????? ???????????
????????????????????????? ?????????????????????????
have also suggested some modulatory effect of 
elevated TG levels on the production of some 
cytokines when stimulus came from P. gingivalis 
lipopolysaccharides5. Taken together, these data 
may indicate that the effect of periodontal disease 
??????????????????????????????????????????????????
levels of cardiovascular control. Nevertheless, this 
effect should be explored in the future for better 
????????????????????????????????????????????????
of this patient population.
A diagnosis of severe periodontitis was correlated 
with above-median concentrations of cytokines by 
??????????????????????????????????????????????????????
in an attempt to provide a better estimation of the 
clinical relevance of the associations found in the 
linear regression models that used log-transformed 
data (which cannot be directly interpreted). It was 
evidenced that performing a periodontal examination 
for establishing the presence of periodontitis may 
be recommended because sensitivity values were 
close to 80%, indicating that the presence of 
periodontitis will most often be related to above-
median cytokine concentrations. On the other hand, 
when the diagnosis of periodontitis was already 
???????????????????????????????????????????????????
above-median concentrations of cytokines were 
low (PPV range: 51.5–55.9). When the diagnosis 
???? ??????? ??? ???? ???????? ??? ??????????????? ????
???????????????????????????????????????????????????
(66.7) compared with other cytokines.
There is extensive evidence suggesting that 
periodontal disease may be a risk factor for CVD26. 
In contrast, evidence is still emerging to determine 
if periodontal disease may be a prognostic factor in 
patients already diagnosed with coronary disease. 
Risk factors and prognostic factors differ in that 
?????????????????????????????????????????????????????
whereas the second relates to the course of an 
existing disease1?????????????????????????????????
present study in chronic CAD patients. Thus, the 
main focus here was to study periodontal disease in 
the presence of cardiovascular disease, potentially 
attributing a perspicuous factor in the disease 
process. It will be reasonable to assume that such 
marker (periodontal disease) could play a prognostic 
role in the history of CVD. Noteworthy, this study is 
?????????????????????????????????????????????????????
????????????????????????????????????????????????????
by Luminex in CAD patients. Previous studies 
support a possible role of periodontal disease in 
?????????????????????????????????????????????????
periodontal parameters and IL-6 and TNF-?10,17,25.
Findings of the present study should be analyzed 
in view of its possible limitations. The results of the 
????????????????????????????????????????? ????????????
because of the loss of statistical power. Another 
limitation may include the cross-sectional nature, 
which precludes causal inferences from being drawn 
from the associations. Luminex analyses were 
performed in uniplicate because of costs, and this 
may have lowered the precision of the readings. 
The storage time of the samples of two years may 
be a limitation; however, there is evidence that the 
?????????? ?????????? ??? ????? ?????? ??????? ???????
during this period of time6,31.
This study applied well-established methodologies, 
?????? ???????????? ???? ????????? ?????????? ?????
measured by the Multiplex technology that allows 
fast, reliable, and accurate quantification of 
???????????????????????????????????????????????????????????????????????????????????????????????????
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biomarkers in the blood. The analyses controlled 
for possible confounding effects by applying 
multivariable models. Moreover, periodontal 
examinations were conducted using a full-mouth 
protocol of six sites per tooth to avoid assessment 
bias24. A broad range of periodontal parameters was 
???????????????????????????????????????????????????
and to associate parameters with blood levels of 
cytokines.
CONCLUSIONS
Periodontal disease is associated with increased 
????????? ???????????? ????????????????????????????
Greater CA loss and PD were associated with higher 
???????????????????????????????????????, even after 
controlling for important confounders.
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